BIOCAD is a leading innovative biotechnology company in Russia; it combines world-class research and development centers, ultra-modern pharmaceutical and biotechnology manufacturing facilities, and preclinical and clinical research infrastructure that conforms to international standards. BIOCAD is one of the few full-cycle drug development and manufacturing companies in the world, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD medicines are dedicated to treating complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders